Digital Therapeutics Show Promise in Pediatric Healthcare

Strategic Insights -

Research published in the Cureus journal highlights the emerging role of digital therapeutics in pediatric healthcare, particularly in addressing attention-deficit/hyperactivity disorder (ADHD) and other developmental conditions. According to the study, digital therapeutics have the potential to deliver scalable, cost-effective, and engaging interventions that expand access to high-quality care for children worldwide. However, several barriers to implementation remain, including access constraints, socioeconomic disparities, and variability in insurance reimbursement.

Key Takeaways:

  • The study focuses on the current landscape of prescription digital therapeutics for children and adolescents, highlighting their potential to complement traditional treatment approaches in specific contexts.
  • Research is rapidly expanding into a broader set of conditions, including autism spectrum disorders, anxiety, substance use prevention, and management of chronic illnesses.
  • Emerging technologies such as artificial intelligence-driven personalization, immersive virtual and augmented reality environments, and integration with wearable devices offer opportunities to overcome current limitations in pediatric digital therapeutics.
  • The study identifies several barriers to implementation, including the digital divide, socioeconomic disparities, and variability in insurance reimbursement.
  • Pediatric digital therapeutics hold promise as tools that may advance precision medicine, though current evidence is limited mainly to a few conditions, such as ADHD and amblyopia.
  • Valley Children's Healthcare is a key organization in the development and implementation of pediatric digital therapeutics.

Statistics:

  • Only a limited number of prescription digital therapeutics have been formally authorized for pediatric use, emphasizing the need for further research and development.
  • Research is rapidly expanding into a broader set of conditions, including autism spectrum disorders, anxiety, and substance use prevention.
  • The study highlights the potential of digital therapeutics to deliver scalable, cost-effective, and engaging interventions that expand access to high-quality care for children worldwide.
  • The digital divide and socioeconomic disparities remain significant barriers to the implementation of pediatric digital therapeutics.

Sources:

  • Pediatric Applications of Digital Therapeutics: Clinical Evidence and Implementation Landscape, Cureus, 2025;17(9).
  • NewsRx. Data on Attention Deficit Hyperactivity Disorders Described by Researchers at Valley Children's Healthcare (Pediatric Applications of Digital Therapeutics: Clinical Evidence and Implementation Landscape). Mental Health Weekly Digest. October 20, 2025; p 151.